Johnson & Johnson Innovative Medicine was named a finalist for the 2026 SCRS Eagle Award
Published
Signal category
Presence & Recognition
Quote
“Johnson & Johnson has been named a finalist for the 2026 SCRS Eagle Award”
— Channia L. Holt|Johnson & Johnson Innovative Medicine team
Company
- Industry
- Pharmaceutical Manufacturing
- Company size
- 39,024 employees
At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK